BIO Waits to Review Obama’s Medicare Drug-Discount Plan

Drug Industry Daily
A A
The Biotechnology Industry Organization (BIO) is taking a wait-and-see approach to a new proposal hammered out over the weekend in which the drug industry would commit $80 billion to give 50 percent discounts on prescription drugs for Medicare beneficiaries.

To View This Article:

Login

Subscribe To Drug Industry Daily